Quantum BioPharma Ltd. Cash Flows From Used In Financing Activities Continuing Operations
Quantum BioPharma Ltd. (QNTM) reported Cash Flows From Used In Financing Activities Continuing Operations of $11.62 million for the 12-month period ending 2024-12-31, per its 20-F/A filed 2025-03-31.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations · last filed 2025-03-31
| Period end | Cash Flows From Used In Financing Activities Continuing Operations 12 month |
|---|---|
| 2024-12-31 | $11.62M 20-F/A · filed 2025-03-31 |
| 2023-12-31 | -$3.13M 20-F/A · filed 2025-03-31 |
| 2022-12-31 | -$2.07M 20-F/A · filed 2025-03-31 |
| 2021-12-31 | $38.21M 20-F · filed 2024-04-02 |
| 2020-12-31 | $24.17M 20-F · filed 2023-03-31 |
| 2019-12-31 | $4.01M 40-F · filed 2021-03-17 |